Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05319444
Other study ID # RFarah
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 30, 2022
Est. completion date July 2024

Study information

Verified date August 2023
Source University of Minnesota
Contact Ronda Farah, MD
Phone (612)-625-8625
Email dermresearch@umn.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this study is to evaluate an improvement of scalp health after the use of an investigational off-label WaterPik and brush device aimed to massage and cleanse the scalp.


Description:

Seborrheic dermatitis and dandruff are skin conditions that present with common features and respond similarly to treatments. Dandruff involves flaking skin that can cause irritation and itching. Dandruff only involves the scalp, whereas seborrheic dermatitis can occur on the scalp, face, chest, and retro-auricular areas. Seborrheic dermatitis can also result in itching and flaking, as well as inflammation and erythema. Both dandruff and seborrheic dermatitis are known to be harmful to the scalp. Despite shampoo and washing, one may still continue to have flaking and scale present on the scalp. There are numerous scalp massages and brushes on the consumer market. Waterpik® was FDA approved in 2018 to provide pressured water combined with a powered toothbrush for optimal plaque and particle removal when cleaning the mouth and teeth. Waterpik® now has several products on the market designed for oral health, pet care, and washing in the shower. The off-label design utilizes the Waterpik® device, but with adjustments optimized for scalp health. Through the investigational use of the off-label WaterPik® and brush device, the investigators propose the technique of massage and gentle water pressure will reduce seborrheic dermatitis and dandruff on the scalp.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date July 2024
Est. primary completion date July 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Participants must qualify for one of the following scalp conditions based on clinical opinion of a board-certified dermatologist: healthy scalp, dandruff, seborrheic dermatitis, or hair loss disease - All Women of Child Bearing Potential must indicate use of two of the following contraceptive methods. The WaterPik device uses an ultrasonic technology which includes ultrasound. Unnecessary ultrasound is not recommended for pregnant women. - Combined (estrogen and progestogen containing) hormonal contraception associated with inhibition of ovulation (oral, intravaginal, or transdermal) - Progestogen-only hormonal contraception associated with inhibition of ovulation (oral, injectable, or implantable) - Intrauterine device (IUD) - Intraurerine hormone-releasing system (IUS) - Vasectomized partner - Sexual abstinence - Barrier method, such as a condom Exclusion Criteria: - Non-English speaking - Exclusion related to pregnancy, lactation, or plans to become pregnant over the course of the study (based on self-report from the participant) - Current clinical condition that, in the opinion of the site investigator, would interfere with adherence to study requirements

Study Design


Intervention

Device:
Off-brand Waterpik®
Study staff will use the Waterpik® device and brush for approximately two to five minutes on the participant's scalp until all scale and other debris appears to be resolved. Their scalp will then be rinsed and gently dried with a towel. The off-label design utilizes the Waterpik® device, but with adjustments optimized for scalp health. The device settings are adjustable during the treatment, ranging from settings of 2-10. Study staff plan to utilize the setting of 10 unless the participant indicates discomfort. Investigators attached a small Losophy brush in replacement of the Waterpik® toothbrush. The small Losophy brush was connected to the device via PVC heat shrink and a hole was drilled on the brush in order to deliver water while simultaneously utilizing the brush on the scalp.

Locations

Country Name City State
United States University of Minnesota Minneapolis Minnesota

Sponsors (1)

Lead Sponsor Collaborator
University of Minnesota

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Adherent Scalp Flaking Scale (ASFS) The presence of dandruff flakes adhereing to the scalp in 8 defined areas is rated on a scale of 0-10 per area, where 0 indicates no flakes and 10 indicates heavy flaking. This is combined for total scores ranging from 0-80. 4 weeks
Secondary Change in Erythema Score The presence of erythema is rated on a scale of 0-4, where 0 indicates None, 1 indicates Minimal - barely perceptible erythema, 2 indicates Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema, 3 indicates Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red), and 4 indicates Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema. The higher score means a worse outcome. 4 weeks
Secondary Change in Patient Sensory Assessment of Scalp & Hair Score This Score is based on 12 descriptions that patients rate 0-10 to assess the condition of their scalp and hair. A higher score means a worse outcome. 4 weeks
See also
  Status Clinical Trial Phase
Withdrawn NCT05019066 - Oral Herbal Combination Formulation and Hair Growth in Women N/A
Recruiting NCT05502796 - Natural History and Pathogenesis of Alopecia in Children and Adults
Completed NCT00981461 - Treatment of Androgenetic Alopecia in Females, 9 Beam N/A
Terminated NCT03709563 - Oral Nutraceutical Supplement With Standardized Botanicals in Males With Self-Perceived Thinning Hair and Loss N/A
Completed NCT06095739 - Study to Investigate the Effectiveness of a Topical Cosmetic Formulation DA-OTC-002 N/A
Completed NCT03351322 - ENERGI-F701 for Female Hair Loss Treatment Phase 2
Recruiting NCT06215469 - Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads) N/A
Completed NCT05945979 - Evaluation of the Efficacy of a New Supplement for Hair and Nails - in Vitro, Clinical, Subjective and Instrumental Study N/A
Not yet recruiting NCT05484973 - Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss N/A
Completed NCT06120933 - A Single-Group Clinical Trial Investigating the Effects of a Hair Vitamin Combination on Hair Growth and Hair Health N/A
Withdrawn NCT04379583 - HairDx Analytical Validation Study
Recruiting NCT05970809 - Assessing the Safety and Efficacy of a Novel Microneedling and Laser Device for Male Pattern Hair Loss N/A
Completed NCT00947219 - Treatment of Androgenic Alopecia in Males N/A
Not yet recruiting NCT03155958 - Ocular Finding in Alopecia Areata N/A
Enrolling by invitation NCT06174441 - The Effect of 24-week Dietary Intake of Food Supplements on Hair N/A
Unknown status NCT02393040 - Study to Assess Efficacy of Platelet-Rich Plasma in Androgenetic Alopecia N/A
Completed NCT01016964 - Treatment of Androgenetic Alopecia in Females, 12 Beam N/A
Recruiting NCT06283316 - Systemic Treatments for Alopecia Areata Registry
Completed NCT04249128 - Nourishing Hair, Skin & Nails Supplement Study (Derm Aid) Phase 3
Recruiting NCT06117293 - Safety and Efficacy Evaluation of the Mosaic Ultra Device N/A